Author affiliations: Office of Public Health Genomics, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia (Muin J. Khoury, Marta Gwinn, Wei Yu); Genetics and Aging Research Unit, Massachusetts General Hospital, Charlestown, Massachusetts (Lars Bertram); International Agency for Research on Cancer, Lyon, France (Paolo Boffetta); Molecular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom (Adam S. Butterworth, Julian P. T. Higgins); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland (Stephen J. Chanock, Montserrat Garcia-Closas, Nathaniel Rothman, Thomas R. O'Brien); Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York (Siobhan M. Dolan); Quebec Innovation Center, McGill University, Montreal, Quebec, Canada (Isabel Fortier); MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom (Julian P. T. Higgins); Erasmus University Medical Center, Rotterdam, The Netherlands (A. Cecile J. W. Janssens); National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland (James Ostell); Stanford University Medical Center, Stanford, California (Ryan P. Owen); School of Medicine, University of Washington, Seattle, Washington (Roberta A. Pagon); School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (Timothy R. Rebbeck); Sloan-Kettering Cancer Center, New York, New York (Jonine L. Bernstein); Department of Health Sciences, University of Leicester, Leicester, United Kingdom (Paul R. Burton); Center for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom (Harry Campbell); Division of Epidemiology, University of California at Berkeley, Berkeley, California (Anand Chockalingam); Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Helena Furberg); Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada (Julian Little); Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland (Daniela Seminara, Deborah M. Winn); Division of Epidemiology, Imperial College London, London, United Kingdom (Paolo Vineis); Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece (John P. A. Ioannidis); Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts (John P. A. Ioannidis); and Center for Genetic Epidemiology and Modeling, Tufts Medical Center, Boston, Massachusetts (John P. A. Ioannidis).
Scientific support for Dr. John P. A. Ioannidis was provided through the Tufts Clinical and Translational Science Institute (Tufts University, Boston, Massachusetts) under funding from the US National Institutes of Health/National Center for Research Resources (UL1 RR025752). Drs. Isabel Fortier and Paul R. Burton were supported by the Public Population Project in Genomics (Montreal, Quebec, Canada), which is funded by Genome Canada and Genome Quebec, and PHOEBE [Promoting Harmonisation of Epidemiological Biobanks in Europe], which is funded by the European Union under the Sixth Framework Programme.
The authors thank Drs. Myles Axton, Teri Manolio, and Cynthia Morton.
The findings and conclusions presented in this report are those of the authors and do not necessarily reflect the view of the US Department of Health and Human Services or the official position or policies of the Tufts Clinical and Translational Science Institute.
Conflict of interest: none declared.